Ogino, M; Naiki, T; Orui, H; Kosone, K; Yamazaki, M. Study of method for identifying phenethylamine drugs. JCCL, 11 Feb 2011, 50, 63-82. 627 kB. Japanese, English abstract
EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.
Pawar, RS; Grundel, E. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs). Drug Test. Anal., 1 Mar 2017, 9 (3), 500-517. 601 kB. https://doi.org/10.1002/dta.1980
Cohen, PA; Venhuis, BJ; Brandt, SD. Advancing supplement science: challenges and solutions: Editorial. Drug Test. Anal., 1 Mar 2016, 8 (3-4), e1-e3. 86 kB. https://doi.org/10.1002/dta.1953
Oh, S; Kim, KS; Chung, YS; Shong, M; Park, SB. Anti-obesity agents: A focused review on the structural classification of therapeutic entities. Curr. Top. Med. Chem., , 9 (6), 466–481. 438 kB. https://doi.org/10.2174/156802609788897862
Vajs, V; Djordjević, I; Ljubodrag Vujisić; Milosavljević, SM. NMR spectroscopy in the analysis of illegal drugs. In Chromatographic Techniques in the Forensic Analysis of Designer Drugs; Kowalska, T; Sajewicz, M; Sherma, J, Eds., CRC Press, Taylor & Francis Group, 1 Jan 2018; pp 177–197. 5.4 MB.
Anon. Ordinance amending the Annex to the New Psychoactive Substances Act [Neue-psychoaktive-Stoffe-Gesetz] as well as Annexes to the Narcotics Act [Betäubungsmittelgesetz]. 14 Mar 2019. 704 kB. #Sibutramine